Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Allogeneic HCT Outcomes in MF Patients Exposure to Ruxolitinib During Transplantation

NCT04526223 is registered in ClinicalTrials.gov with xuna as lead sponsor.

NCT NCT04526223
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04526223 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Allogeneic HCT Outcomes in MF Patients Exposure to Ruxolitinib During Transplantation
Lead sponsor
xuna
Phase
Not applicable
Overall status
Unknown status
Start date
April 20, 2017
Completion date
December 31, 2022
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

time of hematopoietic reconstruction